These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3017903)

  • 1. Effect of the radiosensitizer misonidazole and the radioprotector diethyldithiocarbamate on spontaneous metastasis formation of murine tumors.
    Milas L; Hunter N; Basic I; Volpe JP; Tofilon PJ
    Int J Radiat Oncol Biol Phys; 1986 Jul; 12(7):1071-4. PubMed ID: 3017903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of administration schedules on the potentiation of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) by misonidazole in subcutaneous 9L tumors.
    Wong KH; Zhang H; Wallen CA; Wheeler KT
    Int J Radiat Oncol Biol Phys; 1992; 23(4):831-9. PubMed ID: 1618675
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of misonidazole, SR-2508, RSU-1069 and WR-2721 on spontaneous metastases in C57BL mice.
    Kanclerz A; Chapman JD
    Int J Radiat Oncol Biol Phys; 1988 Feb; 14(2):309-16. PubMed ID: 2828290
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitrosourea-misonidazole combination chemotherapy: effect on KHT sarcomas, marrow stem cells and gut.
    Mulcahy RT; Siemann DW; Sutherland RM
    Br J Cancer; 1982 Jun; 45(6):835-42. PubMed ID: 6212075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of misonidazole chemosensitization effect by mild local hyperthermia.
    Wong KH; Urano M
    Int J Radiat Oncol Biol Phys; 1992; 23(3):593-8. PubMed ID: 1612960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo chemosensitization by misonidazole in sensitive and resistant tumor lines.
    Mulcahy RT; Siemann DW
    Cancer Res; 1983 Oct; 43(10):4709-13. PubMed ID: 6883329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of artificial lung metastases by misonidazole.
    Rockwell S; Nierenburg M; Irvin CG
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1395-8. PubMed ID: 6469763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biodistribution of misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) in rats bearing unclamped and clamped 9L subcutaneous tumors.
    Wong KH; Wallen CA; Wheeler KT
    Int J Radiat Oncol Biol Phys; 1989 Jul; 17(1):135-43. PubMed ID: 2745188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemosensitization of the nitrosoureas by 2-nitroimidazoles in the subcutaneous 9L tumor model: pharmacokinetic and structure-activity considerations.
    Wong KH; Wallen CA; Wheeler KT
    Int J Radiat Oncol Biol Phys; 1990 May; 18(5):1043-50. PubMed ID: 2140824
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Recent advances in hypoxic cell radiosensitizer].
    Ono K; Takahashi M; Nishidai T; Shibamoto Y; Abe M
    Gan No Rinsho; 1983 Oct; 29(13):1608-12. PubMed ID: 6230470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vivo cytotoxicity of misonidazole and hyperthermia in a transplanted mouse mammary tumor.
    Lehman CM; Stewart JR
    Radiat Res; 1983 Dec; 96(3):628-34. PubMed ID: 6657927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies in radiosensitizing effects of misonidazole and SR-2508 on C3H/He mouse mammary tumors.
    Ono K; Takahashi M; Nishidai T; Dodo Y; Shibamoto Y; Hiraoka M; Yukawa Y; Abe M
    Radiat Med; 1984; 2(1):71-5. PubMed ID: 6242712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vivo interaction between radiation and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea in the absence or presence of misonidazole in mice.
    Siemann DW; Maddison K; Wolf K; Hill SA; Keng PC
    Cancer Res; 1985 Jan; 45(1):198-202. PubMed ID: 3965132
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Time-dose relationships for simultaneous misonidazole and 1,3-bis(2-chloroethyl)-1-nitrosourea exposures in vitro.
    Mulcahy RT; Dembs N
    Cancer Res; 1983 Aug; 43(8):3539-43. PubMed ID: 6861127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of misonidazole and hyperthermia on the radiosensitivity of a C3H mouse mammary carcinoma and its surrounding normal tissue.
    Overgaard J
    Br J Cancer; 1980 Jan; 41(1):10-21. PubMed ID: 7362770
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Influence of tumor transplantation methods on tumor growth rate and metastatic potential of solitary tumors derived from metastases.
    Volpe JP; Milas L
    Clin Exp Metastasis; 1990; 8(4):381-9. PubMed ID: 2350921
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased therapeutic benefit through the addition of misonidazole to a nitrosourea-radiation combination.
    Siemann DW; Hill SA
    Cancer Res; 1986 Feb; 46(2):629-32. PubMed ID: 3940631
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of CCNU activity by misonidazole in metastases.
    Siemann DW; Alliet KL
    Clin Exp Metastasis; 1987; 5(1):57-63. PubMed ID: 3829497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antitumor and antimetastatic activity of the differentiating agent N-methylformamide in murine tumor systems.
    Iwakawa M; Tofilon PJ; Hunter N; Stephens LC; Milas L
    Clin Exp Metastasis; 1987; 5(4):289-300. PubMed ID: 3665221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced tumor responses through therapies combining CCNU, MISO and radiation.
    Siemann DW; Hill SA
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1623-6. PubMed ID: 6480451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.